Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study.
Senyurek S, Saglam S, Saglam EK, Yanar H, Gok K, Tastekin D, Akbas CK, Sakin ND, Kartal GD, Balik E, Keskin M, Sanli Y, Gulluoglu M, Akgun Z.
Senyurek S, et al. Among authors: sanli y.
Oncol Res. 2023 Jul 21;31(5):689-696. doi: 10.32604/or.2023.030351. eCollection 2023.
Oncol Res. 2023.
PMID: 37547762
Free PMC article.
Clinical Trial.